Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag has changed from v3.5.4 to v3.5.5, signaling a new version of the record display. This likely reflects minor updates or fixes to the page's metadata or UI without changing the underlying study data.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a new release of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check43 days agoChange DetectedThe ClinicalTrials.gov page footer/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a software release rather than a change to the study history details.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated to v3.5.0 (replacing v3.4.3) in the record history.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page history now shows Revision: v3.4.3 as the latest update, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.